Mercredi 22 Mai 2024 - Wednesday, May 22, 2024
|
| 14:30 - 15:00 |
Reception of participants |
| 15:00 - 15:15 |
Welcome and presentation by the organizers |
| 15:15 - 16:00 |
Current needs and challenges of phage therapy: therapeutic failures, production, régulation, etc. |
| Fréderic LAURENT (Inserm U1111-HCL, Lyon, France) |
| SESSION I |
BIOLOGY OF BACTERIOPHAGES |
| 16:00 - 16:45 |
Biology, taxonomy and genetics of phages |
| Laurent DEBARBIEUX (Institut Pasteur, Paris, France) |
| 16:45 - 17:15 |
Coffee break |
| 17:15 - 18:00 |
Diversity and mechanisms of bacterial resistance |
| François ROUSSET (Weizmann Institute of Science, Israël) |
| 18:00 - 18:45 |
Phage experimental evolution |
| Rémy FROISSART (CNRS UMR 5290, Montpellier, France) |
| 18:45 - 19:30 |
In vivo evaluations on animal models (host immune response / phage / bacteria) |
| Laurent DEBARBIEUX (Institut Pasteur, Paris, France) |
| 19:30 |
Dinner |
Jeudi 23 Mai 2024 - Thursday, May 23, 2024
|
| 06:30 - 08:30 |
Breakfast |
| SESSION II |
THERAPEUTIC PHAGES: PREPARATIONS AND USE |
| 08:30 - 09:30 |
Isolation, selection, bioproduction, purification, classical and innovative formulations and quality of therapeutic phages |
| Fabrice PIROT & Frédéric LAURENT (Hospices Civils de Lyon, France) |
| 09:30 - 10:00 |
Phage Susceptibility Testing |
| Camille KOLENDA (Inserm U1111 - HCL, Lyon, France) |
| 10:00 - 10:30 |
Coffee break |
| 10:30 - 11:15 |
Phage therapy and PK/PD: interests and modelling |
| Gregory RESCH (Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse) |
| 11:15 - 11:45 |
Association of bacteriophages and antibiotics and biofilms |
| Luis MELO (University of Minho, Portugal) |
| 11:45 - 12:30 |
Phage engineering, Synthetic phages |
| Raphaël LAURENCEAU (Institut Pasteur, Paris, France) |
| 12:30 - 14:00 |
Lunch |
| SESSION III |
REGULATORY FRAMEWORKS & EUROPEAN EXPERIENCES |
| 14:00 - 14:30 |
Phages in society: Socio-technical realities |
| Charlotte BRIVES (CNRS UMR 5116, Bordeaux, France) |
| 14:30 - 15:15 |
Phage therapy in the human clinic: the Georgian experience |
| Mzia KUTATELADZE (G. Eliava Institute of Bacteriophages, Microbiology and Virology, Georgie) |
| 15:15 - 16:00 |
Phage therapy in the human clinic: the Belgian experience |
| Jean-Paul PIRNAY (Hôpital militaire Reine Astrid, Bruxelles, Belgique) |
| 16:00 - 16:30 |
Coffee Break |
| 16:30 - 17:15 |
Phage therapy in the human clinic: the French experience |
| Alexandre BLEIBTREU (APHP, Paris, France) |
| 17:15 - 18:00 |
Which regulations for phage therapy in Europe for human/vet? |
| To be confirmed |
| 18:00 - 18:45 |
Round table: Which models of development for phage therapy? |
| Alexandre BLEIBTREU, Frédéric LAURENT, Charlotte BRIVES, Jen-Paul PIRNAY, |
| Mzia KUTATELADZE and Grégory RESCH |
| 18:45 - 19:00 |
Presentation of the practical workshops |
| 19:30 - 20:15 |
Cocktail |
| 20:15 |
Dinner |
Vendredi 24 Mai 2024 - Friday, May 24, 2024
|
| 06:30 - 08:30 |
Breakfast |
| SESSION IV |
BACTERIOPHAGES IN ECOSYSTEMS |
| 08:30 - 09:15 |
Bacteriophages and microbiota |
| Luisa De SORDI (Sorbonne University, Paris, France) |
| 09:15 - 10:00 |
Phages for biocontrol in agriculture |
| Clara TORRES-BARCELÓ (INRAE, Avignon, France) |
| 10:00 - 10:30 |
Coffee Break |
| 10:30 - 11:15 |
Phages in the agri-food industry |
| Claire LE HENAFF (University of Bordeaux, France) |
| 11:15 - 12:00 |
Round Table: Which place for phages in the One health approach? |
| C. TORRES-BARCELÓ, C. LE HENAFF, F. LAURENT, R. FROISSART, L. DEBARBIEUX and C. BRIVES |
| 12:00 - 14:00 |
Lunch |
| 14:00 |
Departure |
